Project Details
Description
A Multicenter Phase III randomized, double-blind, placebo-controlled study of the cancer vaccine Stimuvax (L-BLP25 or BLP25 lipsome vaccine)....
| Status | Finished |
|---|---|
| Effective start/end date | 9/10/06 → 12/31/12 |
Funding
- PRA HEALTH SCIENCES
- EMD PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.